Iodine-125 seed brachytherapy for early stage prostate cancer: a single-institution review

PURPOSE: We are reporting the five-year biochemical control, toxicity profile and dosimetric parameters using iodine-125 low dose rate brachytherapy (BT) as monotherapy for early stage prostate cancer at a single institution. MATERIAL AND METHODS: Between April 2006 and December 2010, 169 men with e...

Descripción completa

Detalles Bibliográficos
Autores principales: Zuber, Simon, Weiß, Susan, Baaske, Dieter, Schöpe, Michael, Stevens, Simon, Bodis, Stephan, Zwahlen, Daniel R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4349732/
https://www.ncbi.nlm.nih.gov/pubmed/25880809
http://dx.doi.org/10.1186/s13014-015-0349-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4349732/
https://www.ncbi.nlm.nih.gov/pubmed/25880809
http://dx.doi.org/10.1186/s13014-015-0349-0

Ejemplares similares